Driving imaging science forward

We don't just use existing methods. We take science to the next level.

We are at the forefront when it comes to innovative ways to solve complex problems in clinical trials. We are driving imaging science forward. With our own research & development department, we don’t just use pre-existing methods to help move new drugs forward, we are driven by finding new and better ways of doing this. Together. For drug development. And in a wider perspective, for the future.

Learn more about our internal method development studies, consortia involvement, and support of investigator-initiated studies.

AM-01: Multiparametric MRI in Diabetic Kidney Disease (DKD)

Internal method development study

AM-02: Multiparametric MRI + PET in metabolic dysfunction-associated steatotic liver disease (MASLD)

Internal method development study

AM-03: Metabolic Imaging Neurodegenerative Diabetes (MIND)

Internal method development study

Read more
LITMUS

Consortia collaboration

Read more
TRISTAN

Consortia collaboration

Read more
BEAt-DKD

Consortia collaboration

Read more
IMMUNE-IMAGE

Consortia collaboration

HEROIC

Investigator-initiated study

COCONUT

Investigator-initiated study

DECADE

Investigator-initiated study